Public Offer Successfully Completed
In accordance with Article 50 of the Takeovers Act, with Article 66 of the Securities Market Act, and with the Rules of the Ljubljana Stock Exchange d.d., Ljubljana, Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana,
hereby announces that
With its decision of 21 November 2002, ref.No. 171/51/AG-02-(731), the Securities Market Agency declares that the public offer by the bidder Servipharm AG,c/o Novartis Pharma AG, Lichtstrasse 35. 4056 Basel, Switzerland (“Bidder”) , for the purchase of 1,792,782 common registered Class A voting shares, and 140,394 preference registered Class B voting shares, at a nominal value of 6,000 SIT per share, of the issuer Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana (“Issuer”), being open between 28 September 2002 and 18 November 2002, was
successfully completed.
In its explanation of the decision, the Securities Market Agency indicated that they had been notified by the bidder, in accordance with the stipulations of the Takeovers Act, that the public offer was accepted by 18,151 holders of the Issuer’s shares, holding a total of 1,915,256 shares of the Issuer, regardless of the share class, representing 99.07% of the total share capital. Of the 18,151 shareholders who tendered, 17,624 were holders of common registered Class A shares (holding a total of 1,778,356 common registered Class A shares), and 1,288 were holders of preference registered Class B shares (holding a total of 136,900 preference registered Class B shares). Since the bidder indicated in its prospectus that the minimum number of shares tendered for the bid to be considered successful was 985,920 shares (representing 51% of all the issued shares), the Securities Market Agency declared the offer to be successful.
Lek d.d.